Drugmakers Have Spent Millions Targeting ‘Middlemen’—and It’s Paying Off
From the Center
When President Trump signed an executive order this month to try to reduce drug prices, the pharmaceutical industry scored a big win.
Within 90 days, the order said, Trump’s staff should put together a report “re-evaluating the role of middlemen,” who have been the target of one of the most sweeping and expensive lobbying campaigns in recent years.
Wall Street Journal (News)
AllSides Media Bias Rating: Center
